POSA172 How to Optimize COVID-19 Vaccination Considering Limited Vaccination Capacities: A Decision-Analytic Framework and Modeling Study

por Jahn, B, Sroczynski, G, Bicher, M, Rippinger, C, Mühlberger, N, Santamaria, J, Urach, C, Popper, N, Siebert, U
Publicado 2022

P16 COVID-19 Vaccination Strategies Considering a Vaccine Adapted to a New Variant of Concern: A Decision-Analytic Modeling Study

por Jahn, B., Sroczynski, G., Bicher, M., Rippinger, C., Mühlberger, N., Santamaria, J., Urach, C., Popper, N., Siebert, U.
Publicado 2022

HPR171 COVID 19 Vaccination - How to Support Decisions on Vaccination Prioritization for New Variants of Concern?

por Jahn, B, Sroczynski, G, Bicher, M, Rippinger, C, Mühlberger, N, Santamaria, J, Urach, C, Popper, N, Siebert, U
Publicado 2022

Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria

por Jahn, B., Rochau, U., Kurzthaler, C., Hubalek, M., Miksad, R., Sroczynski, G., Paulden, M., Kluibenschädl, M., Krahn, M., Siebert, U.
Publicado 2015

Evaluation of undetected cases during the COVID-19 epidemic in Austria

por Rippinger, C., Bicher, M., Urach, C., Brunmeir, D., Weibrecht, N., Zauner, G., Sroczynski, G., Jahn, B., Mühlberger, N., Siebert, U., Popper, N.
Publicado 2021